Page 39 - Medication Guide News Today

- Long-term data at the European Hematology Association (EHA) 2022 Congress expands understanding of the impact of Genentech medicines in early-stage blood cancers with the goal of providing patients

RICHMOND, Va., June 9, 2022 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced the acceptance of seven abstracts for presentation at the 84th Annual Scientific Meeting of the College on

EMD Serono Advances Development Programs in Oncology Focusing on Novel Mechanisms and Pathways

A diagnosis made this front-liner realize how essential it is to talk openly about chronic illness.

-- David E. Wheadon, M.D., Elected to the Board as an Independent Director -- -- Henry A. McKinnell, Jr., to Retire from Board -- SAN CARLOS, Calif., May...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Researchers take action after study exposes sexual dysfunction as a potential side effect of several drugs including many antidepressants.

68% of patients receiving Kymriah in the ELARA trial experienced complete response, with an 86% overall response rate, along with a remarkable safety profile1...

68% of patients receiving Kymriah in the ELARA trial experienced complete response, with an 86% overall response rate, along with a remarkable safety profile1...

68% of patients receiving Kymriah in the ELARA trial experienced complete response, with an 86% overall response rate, along with a remarkable saf...